Align Technology Appoints Jennifer L. Davis as President and CEO, Succeeding Joseph Hogan in December 2026
Align Technology, Inc., a global medical device company specializing in digital orthodontics and restorative dentistry, has announced the appointment of Jennifer L. Davis as its next President and Chief Executive Officer, effective December 31, 2026. Davis will succeed Joseph M. Hogan, who has led the company as President and CEO since 2015 and will support the leadership transition before retiring from the Board of Directors in June 2027.
The appointment represents an important leadership transition for Align Technology as the company continues to advance its digital dentistry portfolio, expand its global presence and strengthen its position in clear aligner treatment and digital oral healthcare. Davis brings 33 years of experience in global business leadership, innovation, digital transformation, brand development and organizational management. Her background includes leading Procter & Gamble’s Global Healthcare business, where she oversaw strategy, operational performance, portfolio innovation and customer development across a multibillion-dollar portfolio of healthcare products.
Davis will join Align Technology as CEO-elect and a member of the Board of Directors on November 2, 2026. She will work closely with Hogan and the company’s leadership team during the transition period before formally assuming the President and CEO roles at the end of December.
The company expects the leadership change to build on its existing strategic foundation while creating opportunities to expand its technologies, digital workflows and brands across orthodontics and restorative dentistry. Davis’s experience in consumer healthcare and oral-health businesses is expected to complement Align’s established expertise in clinical science, engineering, software development and digital dental technologies.
Hogan will continue supporting the company and its incoming CEO during the transition. He is scheduled to retire as a member of the Board following the conclusion of its strategy meeting on June 16, 2027.
Align Technology Names an Experienced Global Healthcare Leader
Davis joins Align Technology with extensive experience managing large, complex businesses and bringing healthcare innovations to market. During her most recent role as Chief Executive Officer of Procter & Gamble’s Global Healthcare business, she was responsible for a broad range of strategic and operational functions across a multibillion-dollar portfolio.
Her responsibilities included business strategy, annual performance management, product and portfolio innovation, operations, and customer development. The portfolio included established oral-health and personal-health brands, giving her experience in categories closely connected to Align’s business and its relationships with consumers and healthcare professionals.
Throughout her career, Davis has focused on developing trusted healthcare brands, strengthening customer engagement, commercializing new products and supporting sustainable growth across international markets. These capabilities are relevant to Align’s efforts to expand access to digital orthodontic treatment and encourage broader adoption of digital technologies among dental professionals.
Align Technology operates at the intersection of medical devices, digital technology and oral healthcare. Its products support orthodontists and general dental practitioners in planning and delivering treatment, managing digital dental workflows and providing restorative solutions. The company’s commercial success depends not only on product innovation but also on clinical confidence, practitioner adoption, patient awareness and the effectiveness of its relationships with dental professionals.
Davis’s background in healthcare brand development and customer engagement could support the company’s efforts to strengthen these relationships while extending the reach of its existing product portfolio.
Kevin Conroy, Chairman of Align Technology’s Board of Directors, said Davis’s experience in consumer healthcare and oral health makes her well suited to lead the company into its next phase.
According to Conroy, Davis has spent her career bringing innovations to market, increasing adoption, developing strong organizations and creating sustainable business growth. He added that her commercial and leadership experience complements the company’s existing strengths in clinical, scientific, engineering and software expertise.
The Board believes that this combination of capabilities will help Align continue expanding the impact of its technology and brands for doctors and patients around the world.
Leadership Transition Follows a Decade of Growth Under Joseph Hogan
Hogan has served as President and CEO of Align Technology since 2015. During his tenure, the company significantly expanded its global reach and strengthened its position in digital orthodontics and restorative dentistry.
Under Hogan’s leadership, Align Technology advanced its Invisalign® clear aligner system, strengthened the brand’s global recognition and continued investing in its digital technology ecosystem. The company also expanded the capabilities of the Align™ Technology Digital Platform and developed its broader portfolio of products and services for dental professionals.
Conroy expressed appreciation for Hogan’s contribution to the company, emphasizing the impact of his leadership on customers, employees, shareholders and patients who have benefited from Invisalign treatment.
“On behalf of the Board of Directors, I want to thank Joe for his extraordinary leadership and enduring impact on Align, our customers, employees, shareholders, and the millions of patients whose lives have been changed through Invisalign treatment,” Conroy said.
He noted that Hogan had helped transform Align Technology into a global leader in digital orthodontics and restorative dentistry. The company’s progress during this period included expanding its international presence, developing its digital capabilities and advancing innovation across its technology and service offerings.
Conroy also said that Align Technology has a clear strategy, a strong financial position and an established reputation for clinical and technological expertise. The Board believes the timing is appropriate for the leadership transition and expressed confidence that Hogan’s continued involvement will help ensure an orderly handover.
Hogan’s planned retirement from the Board in June 2027 provides an additional period for Davis to become familiar with the company’s strategic priorities, organizational structure and relationships with key stakeholders.
The transition is designed to maintain continuity while positioning Align Technology to pursue new opportunities in a changing oral healthcare market.
Davis Highlights Align’s Innovation and Patient-Focused Mission
Davis expressed enthusiasm about joining Align Technology, pointing to the company’s purpose, culture of innovation and partnerships with dental professionals as important reasons for her interest in the role.
“Throughout my career, I have been drawn to businesses with a strong sense of purpose, a culture of innovation, and talented people who are passionate about making a difference,” Davis said. “Align Technology embodies all those qualities.”
She highlighted the company’s contribution to the transformation of orthodontics and dentistry through technology, clinical expertise and collaboration with doctors. Davis also emphasized the strength of the Invisalign brand and the opportunity to build on the company’s existing technological capabilities.
As CEO-elect, she intends to learn from Align’s employees, engage with doctors who use its products, and work with business partners and shareholders as the company continues to develop its strategy.
Davis said she looks forward to helping the company expand its position in digital orthodontics and dentistry while bringing its innovations to more healthcare professionals and patients worldwide.
Her comments reflect the importance of maintaining a balance between technological innovation and the practical needs of dental professionals. Successful digital dentistry solutions must integrate with clinical workflows, support treatment planning and execution, and provide value to both practitioners and patients.
By combining her commercial experience with Align’s established technical and clinical capabilities, Davis will be expected to help the company identify opportunities for growth, improve engagement with its customer base and extend the reach of its products.
The transition also comes as digital technologies continue to influence how dental professionals diagnose conditions, plan treatments and manage restorative procedures. Increasing familiarity with digital scanning, treatment visualization and computer-aided design tools creates opportunities for companies that can integrate these capabilities into practical clinical workflows.
Expanding the Invisalign, iTero and exocad Ecosystem
Align Technology’s business is built around a portfolio of products that support digital orthodontics and restorative dentistry. Its major offerings include the Invisalign System, iTero™ intraoral scanners and exocad™ computer-aided design and computer-aided manufacturing (CAD/CAM) software.
The Invisalign System uses a series of clear, removable aligners designed to gradually move teeth according to an individualized treatment plan. Digital planning tools support the development of treatment strategies, while the aligners provide an alternative to conventional fixed orthodontic appliances for appropriate patients.
The system has become a major component of Align’s business and brand identity. Continued growth depends on maintaining relationships with orthodontists and general dental practitioners, improving treatment-related technologies and encouraging patients to explore suitable orthodontic options with qualified professionals.
The iTero portfolio supports digital dental scanning by capturing detailed images of the teeth and oral structures. Intraoral scanning can help dental professionals create digital representations of a patient’s mouth for use in treatment planning, orthodontic workflows and restorative procedures.
These digital records can support communication between clinicians and laboratories while reducing reliance on traditional physical impressions in appropriate cases. Scanner technology also forms part of a broader shift toward digital workflows across dentistry.
Meanwhile, exocad software supports computer-aided design and manufacturing workflows used in restorative dentistry. These tools help dental professionals and laboratories design dental restorations and related solutions based on digital patient information.
The Align Technology Digital Platform connects aspects of the company’s technology ecosystem, supporting digital workflows and interactions among dental professionals and relevant solutions.
Under Davis’s leadership, opportunities may include strengthening integration across these products, expanding adoption among dental professionals and continuing to develop solutions that meet evolving clinical and operational needs.
The company has not announced specific new product launches or changes to its commercial strategy associated with Davis’s appointment. However, the Board has indicated that her experience in healthcare innovation and brand development will be relevant as Align Technology seeks to extend the reach of its existing technologies.
Addressing Opportunities in Digital Oral Healthcare
Align’s leadership transition comes as digital tools continue to gain importance in orthodontics and restorative dentistry. Dental professionals increasingly use digital imaging, scanning and treatment-planning software to support clinical decision-making and improve workflow coordination.
The company’s markets remain underpenetrated, according to Hogan, with further opportunities arising as more doctors adopt digital workflows and more patients seek orthodontic treatment.
In his comments on the transition, Hogan described Align Technology as well positioned to benefit from these developments, citing its leadership team, innovation capabilities, relationships with doctors and established technology portfolio.
“Leading Align Technology has been one of the most rewarding experiences of my career,” Hogan said.
He recalled joining the company with a belief in its potential to transform orthodontics and dentistry, adding that the commitment, creativity and resilience of its employees had been central to its progress.
Hogan also highlighted the opportunity to expand the impact of the Invisalign System, iTero solutions, exocad software and the Align Digital Platform as digital technologies become more widely used across oral healthcare.
He expressed confidence that Davis is the right leader to build on the company’s foundation and support its next phase of growth and value creation.
For Align, future growth will depend on several factors, including the adoption of digital tools by dental professionals, patient demand, competitive developments, continued product innovation and the company’s ability to deliver solutions that fit clinical requirements.
Davis’s experience in global healthcare operations and commercial development could help the company navigate these priorities while maintaining its focus on technology and customer relationships.
Board Confidence in the Company’s Next Chapter
Conroy emphasized that Davis’s leadership capabilities and experience in oral health provide a strong foundation for the next stage of Align’s development.
The Board’s decision reflects an effort to align leadership experience with the company’s opportunities in digital dentistry and healthcare innovation. While Align has established a significant position in clear aligners and digital dental technologies, expanding into new areas and strengthening adoption will require continued investment and effective execution.
The company will also need to maintain its focus on clinical quality, product performance, customer support and the development of trusted relationships with healthcare professionals.
Davis’s appointment is expected to support these priorities as Align continues to build on its global business and technology platform.
Her formal appointment as CEO-elect on November 2, 2026, will begin a transition period during which she will work closely with Hogan before taking over as President and CEO on December 31, 2026. Hogan will remain involved until his planned retirement from the Board following the June 16, 2027, strategy meeting.
Third Quarter 2026 Financial Results and Investor Call
Separately, Align Technology announced that it had released its third-quarter 2026 financial results in a separate press release on October 28, 2026.
The company scheduled a conference call for October 28 at 4:30 p.m. Eastern Daylight Time, or 1:30 p.m. Pacific Daylight Time, to review the quarterly results and respond to questions from participants.
The call was also scheduled to be webcast live through the company’s investor relations website. Investors could access the webcast through the “Events & Presentations” section under “Company Information” at Align Technology Investor Relations. Conference call registration was available through the company’s designated webcast registration page.
According to the company, an archived audio webcast would become available approximately two hours after the call concluded and remain accessible for one month.
The financial update provides additional context for investors assessing Align’s business performance as it prepares for the leadership transition. The company’s financial position, commercial execution and ability to sustain investment in innovation will remain important considerations as it pursues its long-term objectives.
Jennifer L. Davis’s appointment marks a new chapter for Align Technology following more than a decade of leadership under Joseph Hogan. With 33 years of global business experience and a background overseeing a major healthcare portfolio, Davis brings commercial, operational and brand-building expertise relevant to the company’s continued development.
Align plans to build on its position in digital orthodontics and restorative dentistry through its Invisalign clear aligner system, iTero intraoral scanners, exocad software and Align Digital Platform.
As Davis prepares to assume the CEO role, the company will focus on maintaining continuity while pursuing opportunities to expand digital workflows, strengthen relationships with dental professionals and bring innovations to more patients worldwide.
The leadership transition also reflects the growing importance of combining medical device expertise with digital technology and healthcare brand development. Align’s future performance will depend on how effectively it converts its clinical and technological capabilities into broader adoption and sustainable growth.
With Hogan supporting the transition through June 2027, Davis will have an opportunity to build on the company’s existing foundation and guide its next phase of development in the evolving global oral healthcare market.
About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 307 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide.
Over the past 29 years, Align has helped doctors treat approximately 24.2 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.